+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID03647358

Evaluating Iodine-124 PET Imaging for Lesion Dosimetry in Metastatic Thyroid Carcinoma

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-09-10

75

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new diagnostic imaging test using positron emission tomography PET with a radioactive form of iodine called iodine-124 in patients with metastatic thyroid carcinoma. The study aims to measure the amount of radioactive iodine uptake in cancer lesions to determine if radioiodine therapy should continue or if alternative treatments are needed. This is a phase 1 diagnostic trial led by Memorial Sloan Kettering Cancer Center. Participants will receive injections of rhTSH on two consecutive days followed by an oral dose of iodine-124, ranging from 4 to 7 mCi, to allow imaging of tumor uptake. Up to four whole-body PETCT scans will be performed at approximately 24, 48, and 120 hours after iodine-124 administration using specialized PET scanners. A subset of 10 patients may undergo additional PET scans during radioiodine therapy to compare tracer uptake before and during treatment. During the study, participants will undergo multiple PETCT imaging sessions to assess radioactive iodine uptake and clearance in tumor lesions. Researchers will monitor lesion response over a 1-year period using these imaging results. The study involves close observation and data collection through imaging to evaluate the diagnostic value of iodine-124 PET in guiding therapy decisions. The total study duration extends through 2027, with ongoing assessments based on imaging data.

CONDITIONS

Brief Title

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Research Team

R

Ravinder Grewal, MD

S

Steven Larson, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here